Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Solventum Corp. (SOLV)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: SOLV (3-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
AI Based Fundamental Rating
Outstanding Performance
These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.
Analysis of Past Performance
Type Stock | Historic Profit 16.59% | Avg. Invested days 57 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  5.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 13.16B USD | Price to earnings Ratio 27.55 | 1Y Target Price 80.89 |
Price to earnings Ratio 27.55 | 1Y Target Price 80.89 | ||
Volume (30-day avg) 1311773 | Beta - | 52 Weeks Range 47.16 - 85.92 | Updated Date 04/1/2025 |
52 Weeks Range 47.16 - 85.92 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.76 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 5.8% | Operating Margin (TTM) 9.54% |
Management Effectiveness
Return on Assets (TTM) 4.81% | Return on Equity (TTM) 6.55% |
Valuation
Trailing PE 27.55 | Forward PE 13.33 | Enterprise Value 20403142493 | Price to Sales(TTM) 1.59 |
Enterprise Value 20403142493 | Price to Sales(TTM) 1.59 | ||
Enterprise Value to Revenue 2.47 | Enterprise Value to EBITDA 13.36 | Shares Outstanding 173003008 | Shares Floating 138406231 |
Shares Outstanding 173003008 | Shares Floating 138406231 | ||
Percent Insiders 19.94 | Percent Institutions 64.78 |
Analyst Ratings
Rating 3.09 | Target Price 69.67 | Buy - | Strong Buy 1 |
Buy - | Strong Buy 1 | ||
Hold 9 | Sell 1 | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Solventum Corp.
Company Overview
History and Background
Solventum Corp. was spun off from 3M (MMM) on April 1, 2024. While a new entity, its roots are deeply embedded in 3M's healthcare business. Its history is tied to 3M's innovations in healthcare and medical technologies, spanning decades of development and market presence.
Core Business Areas
- Medical Solutions: Wound care, infection prevention, sterilization, and surgical solutions. These products help improve patient outcomes and reduce healthcare costs.
- Health Information Systems: Software and analytics solutions for healthcare providers, payers, and patients. Focus on improving clinical workflows, revenue cycle management, and patient engagement.
- Oral Care Solutions: Dental and orthodontic products for dentists, orthodontists, and consumers, including restoratives, adhesives, and aligners.
- Purification: Filtration and separation technologies for various healthcare and industrial applications, ensuring safe and efficient processes.
Leadership and Structure
Bryan Hanson is the Chief Executive Officer. The organizational structure is likely a typical corporate hierarchy with departments aligned to the core business areas.
Top Products and Market Share
Key Offerings
- Wound Care Dressings: Advanced wound care dressings designed to promote faster healing and reduce infection. Market share within the advanced wound care segment varies geographically and by product category, facing competition from Smith & Nephew (SNN), Convatec (CTEC), and Molnlycke Health Care.
- Health Data Analytics Platforms: Software solutions providing insights into patient data, improving clinical decision-making and operational efficiency. Competitors include Cerner (owned by Oracle), Epic Systems, and Allscripts Healthcare Solutions.
- Dental Aligners and Braces: Orthodontic solutions for straightening teeth. Competition includes Align Technology (ALGN) (Invisalign) and traditional bracket and wire systems.
Market Dynamics
Industry Overview
The healthcare industry is experiencing growth due to an aging population, increasing prevalence of chronic diseases, and technological advancements. Digital health and personalized medicine are key trends.
Positioning
Solventum is positioned as a provider of innovative healthcare solutions, leveraging its history and expertise in materials science and healthcare technology. Competitive advantages include its brand reputation (inherited from 3M), extensive product portfolio, and global reach.
Total Addressable Market (TAM)
The total addressable market for healthcare solutions is estimated to be in the hundreds of billions of dollars globally. Solventum's TAM is influenced by its market segmentation across its specific products and solutions. Its positioning in high growth areas is expected to improve TAM reach.
Upturn SWOT Analysis
Strengths
- Established brand reputation (legacy 3M)
- Diverse product portfolio
- Strong R&D capabilities
- Global distribution network
- Focus on innovation
Weaknesses
- Newly independent company - requires establishing operational efficiency
- Potential for integration challenges
- Dependence on legacy 3M processes
- Brand awareness (as a new entity)
- Requires establishing independent supply chain
Opportunities
- Expanding into emerging markets
- Developing new digital health solutions
- Acquiring complementary businesses
- Capitalizing on the growing demand for personalized medicine
- Leveraging AI and machine learning
Threats
- Increasing competition
- Regulatory changes
- Economic downturns
- Supply chain disruptions
- Rising healthcare costs
Competitors and Market Share
Key Competitors
- MMM
- JNJ
- BSX
- SYK
- ALGN
Competitive Landscape
Solventum faces competition from established healthcare companies with broader product portfolios. Its success will depend on its ability to innovate, execute its strategic initiatives, and differentiate itself in key markets.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth data is limited due to the recent spin-off. Growth was previously tracked under the 3M umbrella.
Future Projections: Analyst estimates for Solventum's future growth are not yet widely available and will develop over the next few quarters of operation as a new entity.
Recent Initiatives: Solventum's most significant recent initiative is the spin-off from 3M. It is focused on streamlining operations and investing in high-growth areas.
Summary
Solventum is a newly independent company spun off from 3M, possessing a legacy of healthcare innovation. Its initial challenge will be establishing independent operational efficiency and brand awareness. The company's strengths lie in its established product portfolio and R&D capabilities, but it must navigate increasing competition and regulatory changes. Future success depends on its ability to capitalize on growth opportunities in digital health and emerging markets.
Similar Companies
ALGN
Align Technology Inc
ALGN
Align Technology Inc
BSX
Boston Scientific Corp
BSX
Boston Scientific Corp
JNJ
Johnson & Johnson
JNJ
Johnson & Johnson
MMM
3M Company
MMM
3M Company
SYK
Stryker Corporation
SYK
Stryker Corporation
Sources and Disclaimers
Data Sources:
- 3M historical data
- Company press releases
- Industry reports
- Market analysis
Disclaimers:
Data and analysis are based on available information and subject to change. Investment decisions should be made with caution and based on individual research and risk tolerance.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Solventum Corp.
Exchange NYSE | Headquaters Maplewood, MN, United States | ||
IPO Launch date 2024-03-26 | CEO & Director Mr. Bryan C. Hanson | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 22000 | Website https://www.solventum.com |
Full time employees 22000 | Website https://www.solventum.com | ||
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wrap, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. Its Purification and Filtration segment provides purification and filtration technologies comprising filters, purifiers, cartridges, and membranes. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.